Literature DB >> 8510010

Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.

K Sathirakul1, H Suzuki, K Yasuda, M Hanano, O Tagaya, T Horie, Y Sugiyama.   

Abstract

The hepatobiliary transport of nonmetabolizable organic anions [cefodizime, dibromosulfophthalein, and indocyanine green (ICG)] was kinetically analyzed in Eisai hyperbilirubinemic rats (EHBR; Sprague-Dawley-derived mutant rats with conjugated hyperbilirubinemia). In EHBR, the biliary excretion of these anions was remarkably impaired, whereas the alteration in initial plasma disappearance was minimal. The kinetic analysis of the disposition of these ligands revealed 1) that the transport rate via bile canalicular membrane was severely impaired in EHBR for cefodizime and dibromosulfophthalein and 2) that the intracellular transport rate of ICG was decreased in EHBR, which contributed more than the decrease in the canalicular membrane transport to the net reduction of the excretion rate of ICG in EHBR. The latter finding was also supported by the in vitro results; the binding of ICG to ligandin(s) in EHBR was less extensive compared with that in normal rats, resulting in the higher distribution of ICG to organelle. Because the ligand molecules bound to organelle diffuse within the cells much more slowly than the molecules in the cytosol, the higher distribution of ICG to organelle in EHBR results in the reduction in the intracellular transport rate. These results indicate that the differential impairment mechanisms can be proposed for the excretion of organic anions: One is the impairment in the transport rate across the canalicular membrane, the other is the impairment in the intracellular transport rate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510010

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

Review 1.  Innovative treatment for hepatocellular carcinoma (HCC).

Authors:  Junichi Kaneko; Takashi Kokudo; Yoshinori Inagaki; Kiyoshi Hasegawa
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-22

2.  Immunocytochemistry for amoxicillin and its use for studying uptake of the drug in the intestine, liver, and kidney of rats.

Authors:  Kunio Fujiwara; Masashi Shin; Tsubasa Miyazaki; Yasuhiro Maruta
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

3.  Determination of the rate-limiting step in the hepatic elimination of YM796 by isolated rat hepatocytes.

Authors:  T Iwatsubo; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

4.  Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats.

Authors:  H Takikawa; N Sano; M Yamanaka
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

5.  Effects of organic anions and bile acid conjugates on biliary excretion of pravastatin in the rat.

Authors:  S Fukumura; H Takikawa; M Yamanaka
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

Review 6.  Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics.

Authors:  M Yamazaki; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

7.  Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.

Authors:  Masakazu Hirouchi; Hiroshi Suzuki; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

8.  Estimation of the three-dimensional pharmacophore of ligands for rat multidrug-resistance-associated protein 2 using ligand-based drug design techniques.

Authors:  Shuichi Hirono; Izumi Nakagome; Rie Imai; Kazuya Maeda; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

9.  Mechanisms of biliary excretion of lithocholate-3-sulfate in Eisai hyperbilirubinemic rats (EHBR).

Authors:  H Takikawa; K Nishikawa; N Sano; M Yamanaka; T Horie
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

10.  Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

Authors:  I Muraoka; T Hasegawa; M Nadai; L Wang; S Haghgoo; O Tagaya; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.